SCHEMBL2415366

SCHEMBL2415366

CC(=O)NCCNc1nc(N2CC(O)CC2C(=O)O)ccc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 11/20 0.36
CYP3A4 P08684 9/20 0.36
CYP2D6 P10635 9/20 0.36
ALDH1A1 P00352 6/20 0.36
CLK4 Q9HAZ1 6/20 0.36
HSD17B10 Q99714 2/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 3/20 0.35
SCN9A Q15858 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
TSHR P16473 4/20 0.34
KDM4E B2RXH2 2/20 0.34
ALOX15 P16050 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
RECQL P46063 1/20 0.34
HBB P68871 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2415787 0.87 GAA (0.38) GAASCN9AKDM4EMAPTP2RY12
SCHEMBL2412757 0.87 GAA (0.38) GAASCN9AP2RY12ATM
SCHEMBL2414979 0.86 GAA (0.39) GAASCN9AP2RY12ATM
SCHEMBL2416112 0.86 CYP1A2 (0.34) CYP1A2CYP3A4CYP2D6ALDH1A1CLK4
SCHEMBL2414382 0.84 CYP1A2 (0.33) CYP1A2CYP3A4CYP2D6ALDH1A1CLK4
SCHEMBL2414702 0.82 GAA (0.41) GAASCN9AP2RY12ATM
SCHEMBL2412722 0.82 HSD11B1 (0.42) CYP1A2CYP3A4CYP2D6ALDH1A1CLK4
SCHEMBL2414686 0.81 MTNR1A (0.35) GAASCN9AATM
SCHEMBL2415416 0.80 HRH4 (0.37) CYP1A2CYP3A4CYP2D6ALDH1A1CLK4
SCHEMBL2410338 0.79 HRH4 (0.39) CYP1A2CYP3A4CYP2D6ALDH1A1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN claimed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN disclosed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US disclosed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US disclosed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres KRT18, DPYD, DSP CYP1A2 1434/4885CYP3A4 2704/4885CYP2D6 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.